An interventional study of Trabeculopuncture in Open Angle Glaucoma and Pseudoexfoliation Glaucoma, sponsored by Wuerzburg University Hospital. Recruiting at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-04-03.
Sponsored by Wuerzburg University Hospital · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 64 studies in Glaucoma, Open-Angle with a site in Germany — 7 open to participants now, 11 under way, none of them phase 3. Glaucoma, Open-Angle · Germany.
Among the 64 studies in Glaucoma, Open-Angle with a site in Germany, this one is the 25th largest by planned enrollment of the 46 interventional ones that give a count, is one of 5 that started in 2023, is one of 22 with no phase, reaches primary completion later than 0 of the 10 other live ones, and was the 62nd registered.
924 studies on the registry are indexed under Glaucoma, Open-Angle; 115 are open to participants now.
Browse Glaucoma, Open-Angle studies →7 of the 64 studies in Glaucoma, Open-Angle with a site in Germany are open now. Recruiting first, the newest first:
Santen SAS · Sites in Germany, Austria, Belgium and 5 more countries
Ages 18–85
Okuvision GmbH · Sites in Germany
Ages 40+
Elios Vision, Inc. · Sites in Germany, Belgium, France and 3 more countries
Ages 40+
Nova Eye, Inc. · Sites in Germany, Spain, United Kingdom
Ages 22+
Nova Eye, Inc. · Sites in Germany, United States
Ages 55+
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 82 Glaucoma, Open-Angle studies recruiting now, 63 (77%) set no upper age limit and 5 (6%) stop at 75 or younger; 5 take children under 18; 11 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
64 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 4 · Phase 3 9 · Phase 4 9
First in 1997; this study’s year is marked. 5 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 55 is below the median of 80 across 692 interventional studies indexed under Glaucoma, Open-Angle.
Median enrollment 60 across the 46 interventional studies, 246 across the 18 observational. Of the 47 that completed or were terminated, 20 (43%) have results posted.
This tab as a report to print or save as PDF → With an account.
54 of 64 have an industry lead sponsor. The 10 most frequent:
Wuerzburg University Hospital is the lead sponsor of 98 studies on the registry; 19 are open to participants now.
Wuerzburg University Hospital has 1 study filed under Glaucoma, Open-Angle — fewer than ten, so there is no comparison to draw.
5 of the studies in Glaucoma, Open-Angle with a site in Germany that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05626491Stanford UniversityElectrical Stimulation for the Treatment of Glaucoma | 2026-12 |
| NCT04524416iSTAR MedicalMINIject Global Long-Term Follow-up Study | 2026-12 |
| NCT05786196Nova Eye, Inc.Multicenter Glaucoma Study Investigating Standalone Canaloplasty | 2026-12 |
| NCT05564091Nova Eye, Inc.Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma | 2027-06 |
| NCT07235592Santen SASPRESERFLO™ MicroShunt XI Observational PMCF Study With no Control Group | 2027-09 |
Add all 5 to your calendar (.ics) → With an account.
Among the 64 studies in Glaucoma, Open-Angle with a site in Germany, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to perform trabeculopuncture a test to determine the distal outflow tract function to predict the success of ab interno trabeculectomy.
The aim of this study is to develop a non-invasive predictive test for the function of the distal outflow tract after ab interno trabeculectomy for open angle glaucoma. We hypothesize that the ocular pressure drop and outflow change after preoperative trabeculectomy may predict the success of ab interno trabeculectomy. The results of this study should allow trabeculopuncture to be used to select the most appropriate procedure for the individual patient.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Individuals undergo neodymium-doped yttrium aluminum garnet (Nd:YAG) trabeculopuncture prior to ab interno trabeculectomy.
Diagnostic Test: Trabeculopuncture
Trabeculopuncture is performed with a Nd:YAG laser on the trabecular meshwork. Four punctures are created along the 180° nasal trabecular meshwork.
IOP
Intraocular pressure measured by Goldmann applanation tonometry
Time frame: before and two hours after trabeculopuncture, one and four weeks postoperatively (after ab interno trabeculectomy), and three months postoperatively
Outflow facility
Outflow facility is measured by the use of a pneumatonometer
Time frame: before and two hours after trabeculopuncture, one and four weeks postoperatively (after ab interno trabeculectomy), and three months postoperatively
Surgical success
surgical success at month three is defined as 20% IOP reduction without increasing the number of glaucoma drops
Time frame: at month three
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Started Jun 2023 (actual). Primary completion is estimated for Dec 2025, 30 months after the start.
Of 101 non-industry interventional studies with no phase under Glaucoma, Open-Angle, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 57. This study's planned 30 months is below that.
Counting every sponsor, half of 171 studies reached it within 35 months; a quarter within 19 and three quarters within 61.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Wuerzburg University Hospital